Name | Botensilimab |
---|
Description | Botensilimab (AGEN 1181), a humanized anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibody, is an innate and adaptive immune activator. Botensilimab can be used for the research of cancer[1]. |
---|---|
Related Catalog | |
In Vitro | Botensilimab 具有增强的 Fc 区,可增加与抗原呈递细胞和自然杀伤细胞上的 FcγR 的结合[1]。 |
References |
No Any Chemical & Physical Properties |